<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">PROCAINE HYDROCHLORIDE <img border="0" src="../images/pr.gif"/></span><br/>(proe'kane)<br/><span class="topboxtradename">Novocain<br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">local anesthetic (ester-type)</span><br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>1%, 2%, 10% injection</p>
<h1><a name="action">Actions</a></h1>
<p>Decreases sodium flux into nerve cell, thus depressing initial depolarization and preventing propagation and conduction of
         the nerve impulse.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Local anesthetic action produces loss of sensation and motor activity in circumscribed areas of the body close to the injection
         or application site.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Spinal anesthesia and epidural and peripheral nerve block by injection and infiltration methods.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Known hypersensitivity to procaine or to other drugs of similar chemical structure, to PABA, and to parabens; generalized
         septicemia, inflammation, or sepsis at proposed injection site; cerebrospinal diseases (e.g., meningitis, syphilis); heart
         block, hypotension, hypertension; bowel pathology, GI hemorrhage. Safety during early pregnancy (category C) or lactation
         is not established.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Debilitated, older adults, or acutely ill patients; obstetric delivery; increased intraabdominal pressure; known drug allergies
         and sensitivities, dysrhythmias; shock.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Spinal Anesthesia</span><br/><span class="rdage">Adult:</span> <span class="rdroute">SC</span> 10% solution diluted with NS at 1 mL/5 sec<br/><br/><span class="indicationtitle">Infiltration Anesthesia/Peripheral Nerve Block</span><br/><span class="rdage">Adult:</span> <span class="rdroute">SC</span> 0.250.5% solution<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Subcutaneous</span><br/><ul>
<li>Reconstitute solution: To prepare 60 mL of a 0.5% solution (5 mg/mL), dilute 30 mL of 1%-solution with 30 mL sterile
            distilled water. Add 0.51 mL epinephrine 1:1000/100 mL anesthetic solution for vasoconstrictive effect (1:200,0001:100,000).
         </li>
<li>Do not use solutions that are cloudy, discolored, or that contain crystals. Discard unused portion of solutions not containing
            a preservative. Avoid use of solution with preservative for spinal, epidural, or caudal block.
         </li>
<li>Inject slowly with frequent aspirations to avoid inadvertent intravascular administration, which can lead to a systemic reaction.</li>
</ul>
<p><span class="routemethod">INCOMPATIBILITIES</span> <span class="incompattype">Solution/</span><span class="incompattype">additive:</span>
<b>Aminophylline, amobarbital, chlorothiazide, magnesium sulfate, phenobarbital, phenytoin, secobarbital, sodium bicarbonate.</b>
</p>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Anxiety, nervousness, dizziness, circumoral paresthesia, tremors, drowsiness, sedation, convulsions, <span class="speceff-life">respiratory arrest</span>. With spinal anesthesia: postspinal headache, arachnoiditis, palsies, spinal nerve paralysis, meningism. <span class="typehead">Special Senses:</span> Tinnitus, blurred vision. <span class="typehead">CV:</span> Myocardial depression, arrhythmias including bradycardia (also fetal bradycardia); hypotension. <span class="typehead">GI:</span> Nausea, vomiting. <span class="typehead">Skin:</span> Cutaneous lesions of delayed onset, urticaria, pruritus, angioneurotic edema, sweating, syncope, <span class="speceff-life">anaphylactoid reaction</span>. <span class="typehead"> Urogenital:</span> Urinary retention, fecal or urinary incontinence, loss of perineal sensation and sexual function, slowing of labor and increased
      incidence of forceps delivery (all with caudal or epidural anesthesia). 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> May antagonize effects of <span class="classification">sulfonamides</span>; increased risk of hypotension with <span class="classification">maoi</span>s, <span class="classification">antihypertensives</span>. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Rapidly absorbed from injection site. <span class="typehead">Onset:</span> 25 min. <span class="typehead">Duration:</span> 1 h. <span class="typehead">Metabolism:</span> Hydrolyzed by plasma pseudocholinesterases. <span class="typehead">Elimination:</span> 80% of metabolites excreted in urine. <span class="typehead">Half-Life:</span> 7.7 min. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Be aware that reactions during dental procedure are usually mild, transient, and produced by epinephrine added to local anesthetic
            (e.g., headache, palpitation, tachycardia, hypertension, dizziness).
         </li>
<li>Use procaine with epinephrine with caution in body areas with limited blood supply (e.g., fingers, toes, ears, nose). If used,
            inspect particular area for evidence of reduced perfusion (vasospasm): Pale, cold, sensitive skin.
         </li>
<li>Hypotension is the most important complication of spinal anesthesia. Risk period is during first 30 min after induction and
            is intensified by changes in position that promote decreased venous return, or by preexisting hypertension, pregnancy, old
            age, or hypovolemia.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Understand that that there will be temporary loss of sensation in the area of the injection.</li>
<li>Do not consume hot liquids or foods until sensation returns when drug used for dental procedure.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>